Abstract
An in vitro placental barrier model based on human choriocarcinoma BeWo b30 cell line was considered as a method of preclinical study of the transport and toxicity of antitumor agents and other organic compounds. Low permeabilities were found for 5-fluorouracil as an example of hydrophilic compound and for doxorubicin as an example of a lipophilic compound with a high degree of binding to proteins and DNA and a high permeability was found for cyclophosphamide as an example of lipophilic compound with a low degree of binding to proteins. Using impedance spectrometry and cell viability assessment via reduction of resazurin to resorufin, a pronounced cytotoxic effect of doxorubicin and good tolerance of 5-fluorouracil and cyclophosphamide by the cells were shown for drug concentrations equal to the maximum concentrations in the patients’ blood during the treatment of breast cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, A. Jemal, CA. Cancer J. Clin., 2018, 68, 394.
P. Brownbill, I. Chernyavsky, B. Bottalico, G. Desoye, S. Hansson, G. Kenna, L. E. Knudsen, U. R. Markert, N. Powles-Glover, H. Schneider, L. Leach, Reprod. Toxicol., 2016, 64, 191.
E. N. Knyazev, D. V. Mal'tseva, A. A. Zakharyants, G. S. Zakharova, O. V. Zhidkova, A. A. Poloznikov, Bull. Exp. Biol. Med., 2018, 164, 749.
E. N. Knyazev, D. V. Mal'tseva, A. A. Zacharyants, G. S. Zakharova, O. V. Zhidkova, A. A. Poloznikov, Bull. Exp. Biol. Med., 2018, 164, 757.
P. L. Grigsby, Semin. Reprod. Med., 2016, 34, 11.
S. V. Nikulin, E. N. Knyazev, T. N. Gerasimenko, S. A. Shilin, I. N. Gazizov, G. S. Zakharova, A. A. Poloznikov, D. A. Sakharov, Mol. Biol., 2019, 53, 411.
S. Conings, F. Amant, P. Annaert, K. Van Calsteren, J. Pharmacol. Toxicol. Methods, 2017, 88, 25.
K. A. Fomicheva, A. I. Osip'yants, E. N. Knyazev, T. R. Samatov, M. Y. Shkurnikov, Bull. Exp. Biol. Med., 2017, 162, 792.
C. Blundell, Y.-S. Yi, L. Ma, E. R. Tess, M. J. Farrell, A. Georgescu, L. M. Aleksunes, D. Huh, Adv. Healthc. Mater., 2018, 7, 1700786.
J. S. Lee, R. Romero, Y. M. Han, H. C. Kim, C. J. Kim, J.-S. Hong, D. Huh, J. Matern. Fetal. Neonatal Med., 2016, 29, 1046.
E. N. Knyazev, G. S. Zakharova, L. A. Astakhova, I. M. Tsypina, A. G. Tonevitsky, G. T. Sukhikh, Bull. Exp. Biol. Med, 2019, 166, 321.
E. N. Knyazev, V. A. Petrov, I. N. Gazizov, T. N. Gerasimenko, I. M. Tsypina, A. G. Tonevitsky, G. T. Sukhikh, Bull. Exp. Biol. Med., 2019, 166, 369.
E. G. Rudimov, E. N. Knjazev, N. A. Khaustova, O. V. Gri-gorieva, L. B. Buravkova, Dokl. Biochem. Biophys., 2017, 472, 1.
C. N. Cordeiro, M. L. Gemignani, Breast J., 2017, 23, 200.
H. H. Yu, P. S. Cheung, R. C. Leung, T. N. Leung, W. H. Kwan, Hong Kong Med. J. = Xianggang yi xue za zhi, 2017, 23, 387.
L. Knabben, M. D. Mueller, Horm. Mol. Biol. Clin. Investig., 2017, 32
D. B. Longley, D. P. Harkin, P. G. Johnston, Nat. Rev. Cancer, 2003, 3, 330.
A. Emadi, R. J. Jones, R. A. Brodsky, Nat. Rev. Clin. Oncol., 2009, 6, 638.
A.-M. Meredith, C. R. Dass, J. Pharm. Pharmacol, 2016, 68, 729.
C. J. Bode, H. Jin, E. Rytting, P. S. Silverstein, A. M. Young, K. L. Audus, Methods Mol. Med., 2006, 122, 225.
D. Jamieson, J. Lee, N. Cresti, R. Jackson, M. Griffin, J. Sludden, M. Verrill, A. V Boddy, Cancer Chemother. Pharmacol, 2014, 74, 667.
H. Li, B. van Ravenzwaay, I. M. C. M. Rietjens, J. Louisse, Arch. Toxicol, 2013, 87, 1661.
D. S. Wishart, Y. D. Feunang, A. C. Guo, E. J. Lo, A. Marcu, J. R. Grant, T. Sajed, D. Johnson, C. Li, Z. Sayeeda, N. Assempour, I. Iynkkaran, Y. Liu, A. Maciejewski, N. Gale, A. Wilson, L. Chin, R. Cummings, D. Le, A. Pon, C. Knox, M. Wilson, Nucleic Acids Res., 2018, 46, D1074.
A. Takagi, T. Nishimura, T. Akashi, M. Tomi, E. Nakashima, Drug Metab. Pharmacokinet., 2017, 32, 151.
K. Van Calsteren, R. Verbesselt, J. Beijnen, R. Devlieger, L. De Catte, D. C. Chai, R. Van Bree, L. Heyns, J. de Hoon, F. Amant, Gynecol. Oncol, 2010, 119, 594.
K. Van Calsteren, R. Verbesselt, R. Van Bree, L. Heyns, E. de Bruijn, J. de Hoon, F. Amant, Reprod. Sci., 2011, 18, 57.
K. Van Calsteren, D. Hartmann, L. Van Aerschot, R. Verbesselt, R. Van Bree, R. D'Hooge, F. Amant, Neuro-toxicology, 2009, 30, 647.
P. Grohard, J. P. Akbaraly, M. C. Saux, S. Gimenez, J. Robert, A. Brachet-Liermain, J. J. Leng, J. Gynecol. Obstet. Biol. Reprod. (Paris), 1989, 18, 595.
S. V Nikulin, E. N. Knyazev, A. A. Poloznikov, S. A. Shilin, I. N. Gazizov, G. S. Zakharova, T. N. Gerasimenko, Mol. Biol, 2018, 52, 577.
S. V Nikulin, E. N. Knyazev, T. N. Gerasimenko, S. A. Shilin, I. N. Gazizov, G. S. Zakharova, A. A. Poloznikov, M. Y. Shkurnikov, Bull. Exp. Biol. Med., 2018; doi:10.1007/sl0517-018-4283-7.
D. Sakharov, D. Maltseva, E. Knyazev, S. Nikulin, A. Poloznikov, S. Shilin, A. Baranova, I. Tsypina, A. Tonevitsky, BMC Syst. Biol, 2019, 13, 19.
C. S. V Nikulin, N. A. Mnafki Krainova, S. A. Shilin, I. N. Gazizov, D. V Maltseva, Mol. Biol, 2018, 52, 583.
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was carried out using the research equipment of the Center for Collective Use “Post-Genomic and Metabolomic Investigation Methods in Molecular Biology” based on the LLC Research and Development Center BioClinicum.
This work was financially supported by the Ministry of Science and Education of the Russian Federation (Federal Target Program “Research and Development along the Priority Trends of the Science and technology Sector of Russia for 2014–2020” (Project No. RFMEFI58817X0007)).
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 12, pp. 2344–2349, December, 2019.
Rights and permissions
About this article
Cite this article
Knyazev, E.N., Nikulin, S.V., Khristichenko, A.Y. et al. Transport and toxicity of 5-fluorouracil, doxorubicin, and cyclophosphamide in in vitro placental barrier model based on BeWo b30 cells. Russ Chem Bull 68, 2344–2349 (2019). https://doi.org/10.1007/s11172-019-2709-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-019-2709-7